Eric Schlorff - 31 Aug 2023 Form 4/A - Amendment Insider Report for SeaStar Medical Holding Corp (ICU)

Role: Chief Executive Officer, Director
Signature: /s/ Eric Schlorff
Issuer symbol: ICU
Transactions as of: 31 Aug 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 28 Nov 2023, 21:41:03 UTC
Date Of Original Report: 12 Sep 2023
Previous filing: 28 Nov 2023
Next filing: 19 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICU	Common Stock, par value $0.0001 per share	Award	$0	+33,750	+4.8%	$0.000000	736,466	31 Aug 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ICU	Stock Option (Right to Buy)						99,724	31 Aug 2023	Common Stock	99,724	$1.84	Direct	F2
holding	ICU	Stock Option (Right to Buy)						17,986	31 Aug 2023	Common Stock	17,986	$10.00	Direct	F3
holding	ICU	Stock Option (Right to Buy)						83,985	31 Aug 2023	Common Stock	83,985	$0.5300	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Due to an administrative error, the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently overstated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1,428 shares. This error has been corrected on this Form 4.
F2	All options reported herein will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant.
F3	These options are fully vested.
F4	The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from February 20, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from February 20, 2021.